Workflow
Biomarker Strategy
Identify, prioritize, and contextualize biomarkers based on disease biology, clinical relevance, competitive landscape, assay feasibility, and development value.
View workflowBioArchai / Archai Nexus™
Agentic AI for Biomarker-Driven Precision Medicine
BioArchai builds disease-specific intelligence solutions that help biopharma teams transform complex biological evidence into explainable, decision-ready strategy.
Evidence + Data
Biological evidence
Clinical context
Assay signals
Archai Nexus
Unifying intelligence layer
Decision Outputs
Prioritized biomarkers
Trial rationales
Evidence roadmaps
Archai Nexus
The Intelligence Layer Behind BioArchai
Archai Nexus connects biological evidence, biomarkers, assays, clinical context, and expert decision logic to power BioArchai applications across therapeutic development, diagnostics, and evidence generation.
01
Evidence Inputs
Biological literature, clinical data, biomarker landscapes, assay constraints, standards, and stakeholder needs.
02
Archai Nexus
Disease-specific evidence synthesis, traceability, expert logic, configurable scoring, and decision support workflows.
03
Solutions + Applications
Biomarker strategy, trial planning, assay strategy, evidence generation, and team-configured product experiences.
04
Decision-Ready Outputs
Prioritized recommendations, evidence summaries, risk flags, roadmaps, and stakeholder-ready reports.
Solutions
Biomarker Intelligence Across Strategy, Trials, Assays, and Evidence
BioArchai supports disease-specific workflows across the precision medicine lifecycle, powered by Archai Nexus.
Workflow
Clinical Trial Planning
Support translational and clinical teams in planning biomarker-informed development strategies from early clinical hypotheses through Phase I-III decisions.
View workflowWorkflow
Diagnostic & Assay Strategy
Evaluate assay options and testing pathways needed to support biomarker-driven programs with vendor-agnostic strategy and implementation risk flags.
View workflowWorkflow
Evidence Generation
Plan evidence packages that support clinical utility, medical value, diagnostic adoption, stakeholder confidence, and value communication.
View workflowApplications
Configured for the Teams Driving Precision Medicine
BioArchai applications are powered by Archai Nexus and tailored to therapeutic, diagnostic, and evidence-generation teams.
Tx Archai
For pharma translational, biomarker, and clinical trial teams moving from biological rationale and fragmented evidence to biomarker-informed clinical strategy.
- Biomarker strategy
- Patient enrichment
- Phase I-III decision support
Dx Archai
For diagnostics, assay planning, and biopharma partnership teams translating testing capabilities and biomarker data into pharma-facing strategy.
- Diagnostic and assay strategy
- CDx / IVD planning support
- Partnership evidence packages
Evidence Archai
For Medical Affairs, HEOR, RWE, and evidence generation teams shaping stakeholder-ready strategies for scientific engagement and value communication.
- Clinical utility evidence
- RWE study concepts
- Medical and value narratives
Why BioArchai
Built for Biological Complexity. Designed for Expert Judgment.
BioArchai is designed for teams who need explainable, disease-specific reasoning rather than generic AI summaries or disconnected evidence repositories.
Disease-specific intelligence
Contextual reasoning shaped around disease biology, clinical reality, and biomarker maturity.
Evidence traceability
Outputs are grounded in sourceable evidence, rationale, and clear decision logic.
Human-in-the-loop
Built for expert review, calibration, and judgment at the points where decisions matter.
Configurable scoring
Support for disease, stage, evidence, assay, and stakeholder-specific criteria.
Vendor-agnostic strategy
Assay and diagnostic pathways can be evaluated without forcing a single vendor lens.
Decision-ready reports
Recommendations, evidence summaries, gaps, and next steps packaged for team alignment.
Mission
Bring biological reasoning and AI-native workflow intelligence together.
BioArchai exists to improve precision medicine and drug development decisions by helping teams move from fragmented biological and clinical evidence to clearer, explainable, biomarker-driven strategy.
Read the missionTeam
Built by experts across precision medicine, genomics, oncology, diagnostics, and AI product strategy.
The first version includes founder and advisor placeholders so BioArchai can add profiles as the team page is finalized.
View teamInsights
Latest Thinking from BioArchai
Perspective
Why biomarker strategy needs disease-specific intelligence
A forthcoming perspective on connecting mechanism, clinical context, and assay feasibility.
Platform Note
From evidence fragments to decision-ready outputs
A practical view of traceability, prioritization, and expert review in biomarker workflows.
Company Update
Design partner opportunities for Archai Nexus
BioArchai is preparing early collaboration pathways for qualified biopharma and diagnostic teams.
Careers
Build the future of AI-enabled precision medicine.
BioArchai is not listing open roles yet, but the careers page is ready for future opportunities and relevant introductions.
Ready to explore Archai Nexus?